[PCRX] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
03-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -93.39%
YoY- -386.12%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 181,244 163,926 169,467 160,341 171,955 167,466 169,411 4.59%
PBT 33,720 16,601 37,854 -26,474 -18,068 2,069 22,007 32.80%
Tax 8,850 5,743 12,091 -6,938 -7,966 2,762 2,131 157.69%
NP 24,870 10,858 25,763 -19,536 -10,102 -693 19,876 16.07%
Tax Rate -26.25% -34.59% -31.94% - - -133.49% -9.68% -
Total Cost 156,374 153,068 143,704 179,877 182,057 168,159 149,535 3.01%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 13.72 6.62 15.20 -12.18 -5.87 -0.41 11.73 10.98%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 0.54 0.23 0.56 -0.43 -0.22 -0.02 0.40 22.08%
EPS Diluted 0.48 0.23 0.49 -0.43 -0.22 -0.02 0.38 16.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.